SLC10A1 and cholestasis: Nevertheless, CsA inhibits NTCP as well as other transporters, such as the organic anion transporting polypeptide, at even lower concentrations80, which may lead to a higher risk of cholestasis compared Myrcludex B. As a consequence, the usefulness of CsA as an agent to treat HBV and HDV infection remains to be seen.